PolicyWinds
Topic and direction labels are AI-assisted, and each one quotes the bill text it is based on. How labels work
New York · 2025-2026 General Assembly

A02145 Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.

Direction

Abortion medication abortionAI label

Expands abortion access model confidence 80%

Allows prescription labels for mifepristone and misoprostol to use a health care practice name instead of the individual prescriber or dispenser name (at the prescriber's request), which can reduce privacy and safety risks for abortion providers and thereby facilitate medication abortion provision.

at the prescriber's request, the prescription label for mifepristone, misoprostol, and their generic alternatives may include the name of the prescribing health care practice instead of the name of the prescriber.

✓ Quote verified word for word in the bill text

Abortion provider clinic regulationAI label

Expands abortion access model confidence 70%

Permits prescription labels for mifepristone and misoprostol to substitute a health care practice name for the individual prescriber or dispenser name, easing certain labeling requirements that can expose providers to harassment and thereby supporting abortion clinics and providers.

Notwithstanding subdivision one of this section, at the prescriber's request, the prescription label for mifepristone, misoprostol, and their generic alternatives may include the name of the prescribing health care practice instead of the name of the prescriber.

✓ Quote verified word for word in the bill text

  1. Filed (completed)
  2. Committee
  3. Passed one chamber
  4. Passed both
  5. Governor
  6. Law

Status: Died (session ended)

Last action
2025-01-22: substituted by s36a
Filed
2025-01-15
Sponsor
Karines Reyes D + 6 cosponsors (6 D)

Why the model tagged it this way: The bill addresses only labeling rules for the two drugs used in medication abortion (mifepristone and misoprostol), with the change designed to protect provider privacy and thereby expand access to abortion services; no other listed topics are substantively addressed.

Related bills

Hearings and calendar

Votes

DateChamberMotionYea-Nay
2025-01-22AAssembly Higher Education Committee: Favorable refer to committee Rules17-8Passed
2025-01-22AAssembly Rules Committee: Favorable21-8Passed

Sponsors

Text versions

History (8 actions)
DateChamberAction
2025-01-22Asubstituted by s36a
2025-01-22Aordered to third reading rules cal.61
2025-01-22Arules report cal.61
2025-01-22Areported
2025-01-22Areported referred to rules
2025-01-16Aprint number 2145a
2025-01-16Aamend (t) and recommit to higher education
2025-01-15Areferred to higher education